✦ LIBER ✦

Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial

✍ Scribed by Myra F. Barginear, Richard J. Gralla, Thomas P. Bradley, Syed S. Ali, Iuliana Shapira, Craig Greben, Nanette Nier-Shoulson, Meredith Akerman, Martin Lesser, Daniel R. Budman

Book ID: 118787147
Publisher: Springer-Verlag
Year: 2012
Tongue: English
Weight: 194 KB
Volume: 20
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s00520-012-1413-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB